Ranitidine Injection Usp (2020-08-27)
Ranitidine Injection USP Recall Summary Ranitidine Injection USP has been recalled across Canada due to product safety concerns. This recall affects the injectable form of ranitidine, a medication used to reduce stomach acid. The recall is classified as Class I, indicating a serious safety issue.
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2020-08-27
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/1372c0bf-e2b5-4222-9920-67b4ea2454f1